Massachusetts State House
Rare disease advocates have joined with the National Organization for Rare Disorders (NORD), the national sponsor of Rare Disease Day in the US, to organize this special event for legislators, legislative staff, the public and the media.
"Cydan is proud to be a sponsor of the ReACT Congress 2016. Our aim is to promote research on rare and orphan diseases among the general public, industry and policymakers as well as to provide a forum for researchers to meet and pool their knowledge."
Westin Copley Place
James McArthur, CSO of Cydan Development and CEO of Imara, Inc. will be speaking on the Cydan model and “An Alternative Path for Rare Disease Therapeutics.” In addition, Dione Kobayashi, VP of Preclinical Translation of Cydan Development will be participating on a panel entitled, "Identification and Characterization of Orphan Disease Targets."